ʻO ka hoʻohana ʻana i ka opioid e nā maʻi maʻi maʻi maʻi i hāʻule a hoʻopaʻa ʻia paha ma hope o ka loaʻa ʻana o kahi mea hoʻoulu ʻana i ka spinal cord, e like me kahi noiʻi hou.
Ua hoʻoikaika nā hopena i nā mea noiʻi e manaʻo e noʻonoʻo nā kauka i ka hoʻoulu ʻana i ka spinal cord stimulation (SCS) no nā poʻe maʻi i ʻoi aku ka ʻeha o ka manawa ma mua o ke kuhikuhi ʻana i nā mea hōʻeha ʻeha, wahi a ka mea noiʻi nui ʻo Ashwini Sharan, MD, i loko o kahi ninaninau.Hāʻawi nā mea hoʻolele uila liʻiliʻi i nā hōʻailona ma o nā alakaʻi uila i hoʻokomo ʻia ma ke kuamoʻo e hoʻopilikia i nā leka ʻeha e hele ana mai nā aʻalolo a i ka lolo.
Ua komo ka haʻawina i ka ʻikepili ʻinikua mai 5476 mau maʻi i loaʻa iā SCS a hoʻohālikelike i nā helu o kā lākou ʻōlelo opioid ma mua a ma hope o ke kanu ʻana.Hoʻokahi makahiki ma hope o ka implant, 93% o nā mea maʻi i hoʻomau i ka hoʻoulu ʻana i ka spinal cord stimulation (SCS) therapy i haʻahaʻa haʻahaʻa i kēlā me kēia lā morphine-equivalent doses ma mua o nā poʻe maʻi i hoʻoneʻe ʻia kā lākou ʻōnaehana SCS, e like me ke aʻo ʻana, a Sharan e manaʻo nei e waiho no ka paʻi.
"ʻO ka mea a mākou i ʻike ai he piʻi nui ka poʻe i kā lākou hoʻohana narcotic i hoʻokahi makahiki ma mua o ka implant," i ʻōlelo ai ʻo Sharan, he loea neurosurgery ma Thomas Jefferson University ma Philadelphia a me ka pelekikena o ka North American Neuromodulation Society.Ua hōʻike ʻo Sharan i nā hopena ma ka hālāwai makahiki o ka hui i kēia pule.
"ʻAʻole nui ka ʻikepili heluna kanaka maikaʻi, ma ke ʻano, e ʻōlelo ana he aha ka pilina ma waena o kēia mau narcotics a me kēia mau implants. ʻO ia ka punchline o kēia, "wahi āna. o ka hoʻohana ʻana i ka hāmeʻa ma ke ʻano he hoʻolālā hoʻemi narcotic no ka mea manaʻoʻiʻo a ʻaʻole paha, ʻaʻole i aʻo ʻia."
ʻAʻole ʻike ka poʻe noiʻi i nā ʻōnaehana SCS o nā mea hana i hoʻokomo ʻia i loko o ka poʻe maʻi nona ka ʻikepili a lākou i aʻo ai, a ʻaʻohe kālā i hoʻopaʻa ʻia no kahi noiʻi hou aku, e like me Sharan.ʻO ka haʻawina mua i kākoʻo ʻia e St. Jude Medical, i loaʻa hou iā Abbott.Ua ʻae ʻo FDA i kā St. Jude's BurstDR SCS system i ʻOkakopa i hala, ʻo ia ka mea hou loa i loko o kahi pūʻulu ʻae SCS.
Ua hele nui ʻo Abbott e hoʻohuli i nā kauka e kuhikuhi i ka opioid painkiller OxyContin i nā makahiki mua o kona loaʻa ʻana, e like me ka hōʻike a STAT News.Ua loaʻa i ka hui nūhou nā moʻolelo mai kahi hihia i lawe ʻia e ka mokuʻāina o West Virginia e kūʻē iā Abbott a me OxyContin mea hoʻomohala ʻo Purdue Pharma LP, me ka ʻōlelo ʻana ua kūʻai pono lākou i ka lāʻau lapaʻau.Ua uku ʻo Purdue i $10 miliona i ka makahiki 2004 e hoʻoponopono i ka hihia.ʻAʻole kekahi hui, ka mea i ʻae e hoʻolaha pū i ka OxyContin, i ʻae i ka hana hewa.
"ʻO SCS ka hopena hope loa," hoʻomau ʻo Sharan."Inā ʻoe e kali i hoʻokahi makahiki no ka mea e ʻaneʻane pālua i kā lākou mau lāʻau narcotic, a laila pono ʻoe e haʻalele iā lākou.
He $5,000 ke kumukūʻai o ka morphine i hoʻokahi makahiki, a ʻo ke kumukūʻai o nā hopena ʻaoʻao e hoʻohui i ka huina, wahi a Sharan.He $16,957 ka awelika o ka spinal cord stimulators ma Ianuali 2015, he 8% mai ka makahiki i hala, e like me ka Modern Healthcare/ECRI Institute Technology Price Index.ʻO nā hiʻohiʻona hou, ʻoi aku ka paʻakikī i hana ʻia e Boston Scientific a me Medtronic ke kumu kūʻai he $19,000, ʻoi aku ma kahi o $13,000 no nā hiʻohiʻona kahiko, hōʻike ka ECRI data.
Ke koho nei nā halemai i nā hiʻohiʻona hou, ua hōʻike ʻo ECRI, ʻoiai ʻo nā mea hou e like me ka hoʻohui ʻana o Bluetooth ʻaʻohe mea e hoʻomaikaʻi ai i ka hōʻeha ʻeha, e like me Sharan.Ua ʻōlelo ka pelekikena o ka hui ua hoʻokomo ʻo ia ma kahi o 300 mau mea hana i ka makahiki, me ka SCS, a hoʻāʻo e hana "i kahi ʻokoʻa nui, ke kamaʻilio wau me nā kauka, ma nā hiʻohiʻona me ka hana.
Ka manawa hoʻouna: Jan-27-2017